Home > Cashflow Statement > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Cashflow Statement

NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Profit Before Tax₹41 Cr₹42 Cr₹36 Cr₹-63 Cr₹12 Cr
Adjustment ₹13 Cr₹10 Cr₹13 Cr₹102 Cr₹8.18 Cr
Changes In working Capital ₹-35 Cr₹23 Cr₹-9.81 Cr₹-19 Cr₹-5.72 Cr
Cash Flow after changes in Working Capital ₹19 Cr₹75 Cr₹39 Cr₹20 Cr₹15 Cr
Cash Flow from Operating Activities ₹18 Cr₹75 Cr₹38 Cr₹17 Cr₹14 Cr
Cash Flow from Investing Activities ₹-3.96 Cr₹-27 Cr₹-2.88 Cr₹-20 Cr₹-21 Cr
Cash Flow from Financing Activities ₹-2.13 Cr₹-7.78 Cr₹-1.67 Cr₹-22 Cr₹5.74 Cr
Net Cash Inflow / Outflow ₹11 Cr₹39 Cr₹34 Cr₹-25 Cr₹-0.81 Cr
Opening Cash & Cash Equivalents ₹77 Cr₹38 Cr₹4.18 Cr₹29 Cr₹3.29 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹89 Cr₹77 Cr₹38 Cr₹4.18 Cr₹2.48 Cr

Compare Cashflow Statement of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹290.1 Cr 0.2% -5.3% -23.4% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹13,272.7 Cr 2% 2.2% -17.8% Stock Analytics
KAVERI SEED COMPANY ₹5,004.0 Cr 0.5% -4.7% 4.2% Stock Analytics
VENKYS (INDIA) ₹2,018.2 Cr -0.4% 7.7% -23.6% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,077.0 Cr 0.6% -7.7% -34.8% Stock Analytics
INDO US BIOTECH ₹249.2 Cr -1.1% -1.6% -65.1% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

0.2%

-5.3%

-23.4%

SENSEX

0.4%

-0.1%

6.1%


You may also like the below Video Courses